Advertisement
Haleon plc

Haleon plc (HLN) Stock Overview

Explore Haleon plc’s financial performance, market position, analyst ratings, and future outlook.

HLNNYSE
HealthcareDrug Manufacturers - Specialty & Generic
$9.13
$0.10(1.11%)
U.S. Market opens in 51h 8m
Advertisement

Haleon plc (HLN)

Meyka AI Score

Z

Key Financials

Market Cap40.3B
P/E Ratio10.91
EPS (TTM)$0.49
ROE0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$8.60
3 Months$6.44
1 Year Target$10.00

HLN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Haleon plc (HLN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.00, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $10.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 10.91 and a market capitalization of 40.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.05%
5-Day Change
0.94%
1-Month Change
0.27%
3-Month Change
-9.38%
6-Month Change
-4.15%
Year-to-Date (YTD) Change
-9.74%
1-Year Change
-17.12%
3-Year Change
12.24%
5-Year Change
21.67%
All-Time (Max) Change
21.67%

Contact Information

44 1932 822000
Building 5, Weybridge, NaN, KT13 0NY

Company Facts

24,561 Employees
IPO DateJul 25, 2022
CountryGB
Actively Trading

Frequently Asked Questions